Ba, H., Liu, L., Peng, Q., Chen, J., & Zhu, Y. (2021). The relationship between blood-based tumor mutation burden level and efficacy of PD-1/PD-L1 inhibitors in advanced non-small cell lung cancer: A systematic review and meta-analysis. BMC.
Cita Chicago Style (17a ed.)Ba, He, Lei Liu, Qiang Peng, Jie Chen, y Yao-dong Zhu. The Relationship Between Blood-based Tumor Mutation Burden Level and Efficacy of PD-1/PD-L1 Inhibitors in Advanced Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis. BMC, 2021.
Cita MLA (8a ed.)Ba, He, et al. The Relationship Between Blood-based Tumor Mutation Burden Level and Efficacy of PD-1/PD-L1 Inhibitors in Advanced Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis. BMC, 2021.
Precaución: Estas citas no son 100% exactas.